Skip to main content
Home Educational Resources Inhalers Breo™ Ellipta™
Breo™ Ellipta™

Breo™ Ellipta™

Generic Name: Fluticasone furoate and vilanterol


Breo™ Ellipta™

Instructions for use

  1. Wash and dry your hands well.
  2. Do not shake the inhaler.
  3. Slide down the cover until you hear a click.
  4. Breathe out through your mouth away from the inhaler.
  5. Close your lips tightly around the moutpiece.
  6. Breathe in deeply through your mouth. Be careful not to block the air vent on the inhaler with your fingers.
  7. Remove the moutpiece and hold your breath for at least 3 to 4 seconds or as long as comfortable.
  8. Breathe out through your mouth slowly, away from the inhaler.
  9. You may not taste or feel the medicine, even when you are using the inhaler correctly. Do not take another dose.
  10. Close the inhaler.
  11. Rinse your mouth or brush your teeth and spit out the water – do not swallow.
  12. Store inhaler in a cool, dry place.

Note: Open the inhaler only if you are ready to take your dose. The counter counts down by 1 each time you open the cover.

Key product details

Medication Class & Use

  • Combination inhaler (maintenance inhaler, long-acting beta-2 agonist (LABA) and corticosteroid). This inhaler combines two medications that work over time to make breathing easier. Together the medications relax the muscles in the airway and decrease inflammation, swelling and mucus production.
  • Use this inhaler every day to prevent symptoms, even when feeling well.
  • Do not use for fast relief.
  • Do not use in combination with other LABA medicines.


  • Maintenance treatment of COPD: 1 inhalation of 100 mcg/25 mcg once daily.
  • Adult asthma: 1 inhalation of 100 mcg/25 mcg or 200mcg/25mcg once daily.
  • Available Strengths: 100mcg/25mcg, 200mcg/25mcg
  • Maximum dosage 200mcg/25mcg per 24 hours
  • Inhaler contains 30 doses (institutional model has 14 doses.)


  • Inhaler is empty when dose counter reads 0 (the counter is red for doses 9-0 to remind getting a refill.)
  • Discard inhaler 6 weeks after opening foil pouch (or when dose counter reads 00, whichever comes first.)


  • Keep inhaler dry at all times. Use a dry cloth to gently wipe mouthpiece if needed.


  • Do not use in combination with other LABA containing medicines for any reason.
  • Do not use if patient has a severe allergy to milk proteins.
  • Long-acting beta2-adrenergic agonists (LABA) increase the risk of asthma-related death. See Black box warning.


  1. Galvin WF, Dunn PJ, Kallstrom TJ. A Patient’s Guide to Aerosol Drug Delivery. American Association for Respiratory Care; 2010.
  2. Product Information: BREO ELLIPTA inhalation powder, fluticasone furoate and vilanterol inhalation powder. GlaxoSmithKline, Research Triangle Park, NC, 27709. 2016.

This site does not endorse or recommend any individual medication and does not accept funding or advertising from drug manufacturers. Our intent is to share information about medication use so that you get the most benefit from your medicine.

The information provided is educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment.

Copyright @2023 Fairview Physician Associates. All rights reserved.